Dimerol MR Tablet 30 mg is a modified-release oral antidiabetic medication containing Gliclazide, designed for the management of type 2 diabetes mellitus. The “MR” (modified release) formulation allows gradual release of the active ingredient over an extended period, providing stable blood glucose control with once-daily dosing. It is particularly suitable for patients who require sustained glycemic control throughout the day while minimizing the risk of hypoglycemia.
Gliclazide belongs to the sulfonylurea class of antidiabetic drugs. It works by stimulating insulin secretion from pancreatic beta cells in response to elevated blood glucose levels. Additionally, Gliclazide may improve peripheral insulin sensitivity and reduce hepatic glucose production. The result is better control of both fasting and postprandial (after meal) blood sugar levels.
Dimerol MR Tablet 30 mg is often used as monotherapy or in combination with other oral antidiabetic agents, such as metformin, depending on the patient’s glycemic status and medical guidance.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Dimerol MR Tablet 30 mg is indicated for:
Management of type 2 diabetes mellitus
Patients whose blood glucose levels are not adequately controlled by diet, exercise, and lifestyle modifications alone
Combination therapy with other oral antidiabetic agents when additional glycemic control is required
It is not indicated for type 1 diabetes or diabetic ketoacidosis.
Adults: The usual starting dose is 30 mg once daily with breakfast or the main meal of the day.
The dose may be adjusted gradually based on blood glucose monitoring and physician guidance.
Maximum daily dose should be as prescribed by the healthcare professional.
Dimerol MR should be swallowed whole and not crushed or chewed to maintain its modified-release properties. Consistent timing of daily administration helps maintain stable blood glucose levels.
Contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe renal or hepatic impairment.
Caution in elderly patients due to higher risk of hypoglycemia.
Patients should be educated on recognizing signs of low blood sugar, such as sweating, tremors, dizziness, and confusion.
Alcohol may increase the risk of hypoglycemia and should be limited.
Regular monitoring of blood glucose is essential to adjust therapy appropriately.
Inform the physician about all concomitant medications to avoid potential interactions.
Dimerol MR Tablet is generally well tolerated. Some patients may experience:
Hypoglycemia (low blood sugar)
Nausea or mild gastrointestinal discomfort
Headache
Weight gain
Skin reactions or rashes (rare)
Severe hypoglycemia is uncommon when the medication is taken correctly but requires immediate medical attention if it occurs.
Store below 30°C in a dry, cool place away from direct sunlight. Keep out of reach of children. Do not crush or split the tablet.
Dimerol MR Tablet 30 mg offers convenient, once-daily glycemic control for patients with type 2 diabetes, helping maintain stable blood sugar levels and improve long-term metabolic outcomes under proper medical supervision.
Login Or Registerto submit your questions to seller
No none asked to seller yet